ASTELLAS PHARMA, INC. (ALPMF)
Clinical trial NCT05756777 updates: 1. start date: 2023-06-26 → 2023-10-25 2. completion date: 2027-02-01 → 2027-04-21 3. primary completion date: 2027-02-01 → 2027-04-21
Clinical trial NCT05756777 updates: 1. start date: 2023-06-26 → 2023-10-25 2. completion date: 2027-02-01 → 2027-04-21 3. primary completion date: 2027-02-01 → 2027-04-21
📉 **NEGATIVE** • Medium confidence analysis (69%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (20%) **Content type:** Clinical